Reigniting the core means being operationally excellent in everything we do. It’s about driving high-quality care consistently and worldwide. It requires us to standardize and improve processes to enable growth. And it will result in focused investments to drive improved outcomes.

Reigniting growth and innovation means we want to lead the market by further enhancing clinical outcomes and patient safety. We will innovate to differentiate and grow profitably by building a global product platform that allows for focused enhancement of treatment pathways and quality. It’s about setting a new standard of care in the U.S. with high-volume hemodiafiltration (HVHDF) and leveraging our product leadership to further expand market share and drive volume growth. It’s about driving an AI-powered transformation in patient care, research, and operations. And it’s about continuing to grow purposefully internationally.

Reigniting our culture means we are people taking care of people, and it’s vital that we also take care of ourselves. We will focus on further developing our people to attract, retain, and engage the very best talent. We want this to be the place where everyone else wants to be; we want to be the employer of choice. It’s everyone’s job to help make this a reality.